glp-1 rfk Will Americans really lose '125 million pounds' from Trump's deal? RFK Jr. Says He Has

A patient can be taking the same dose of thyroid medication and still see a change in TSH because body weight, digestion, and metabolic status are changing in the background

The observed divergence in mortality results when comparing injectable semaglutide to sitagliptin (a placebo proxy) in benchmarking analyses led us to view the results for outcomes containing mortality with skepticism and focused our interpretation on the nonmortality clinical endpoints

Learn here

The GLP-1 companion-supplement market was valued at roughly $735 million in the US in 2025 and is projected to keep growing at a double-digit annual rate through the early 2030s